AEGiS-UNAIDS: Medical Practices Not Primary Mode of HIV Infection in Africa, UN Meeting Finds

Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.

Medical Practices Not Primary Mode of HIV Infection in Africa, UN Meeting Finds

United Nations (New York) - March 14, 2003

Contrary to recent suggestions that a majority of HIV infections in sub-Saharan Africa are due to unsafe medical practices, an expert group convened by the United Nations reaffirmed today that unsafe sex remains the primary mode of transmission in the region.

Following a review of the evidence, experts convened in Geneva by the World Health Organization (<"http://www.who.int/mediacentre/statements/2003/statement5/en/">WHO) and the Joint UN Programme on HIV/AIDS (<"http://www.unaids.org/whatsnew/press/eng/HIVinjections140303_en.html">UNAIDS) concluded that current epidemiological and biomedical data does not support the claim that the majority of HIV infections in sub-Saharan Africa are due to unsafe injections in healthcare contexts.

WHO previously estimated that unsafe injections account for only 2.5 per cent of HIV infections in the region. The meeting participants said today that while they fully agreed that safe medical injections are a crucial component of a comprehensive response to minimize the transmission of HIV, safer sex promotion must remain the primary feature of prevention programmes in sub-Sahara Africa.

The experts cited that age-specific infection rates, for example, strongly follow patterns of sexual behaviour and those of other sexually transmitted infections such as herpes simplex virus-2. In addition, children between 5-14 years, who are generally not yet sexually active, have very low HIV infection rates.

With approximately 3.5 million Africans infected by HIV in 2002 alone, discussions about other modes of transmission should at no time weaken the centrality of the safe-sex part of the response, the experts said.

030314
UN030306

Copyright © 2003 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .